Red Light Therapy for Stretch Marks and Cellulite | NovaThera
Skin & Body

Red light therapy for
stretch marks and cellulite

Two of the most searched cosmetic concerns. One mechanism with real clinical evidence behind it. Here is what the research actually shows - and what it honestly cannot promise.

Red light therapy for stretch marks and cellulite - clinical evidence
June 2026 11 min read Clinical Evidence

Why these two conditions end up in the same conversation

Stretch marks and cellulite are not the same condition, but they share enough biology that it makes sense to address them together. Both involve structural changes in the dermis - the deep layer of skin where collagen and elastin give skin its strength, elasticity, and texture. Both are extraordinarily common. Around 80% of adults have cellulite to some degree. Stretch marks affect roughly the same proportion of women, and a significant number of men, appearing during pregnancy, rapid growth, weight change, or muscle gain. And both have historically been poorly served by treatments that promise more than they deliver.

Red light therapy sits in interesting territory here. It is not a shortcut, and anyone claiming it makes stretch marks disappear or permanently eliminates cellulite is overstating the evidence significantly. What the research does show is that consistent PBM use can produce measurable improvements in collagen density, skin texture, and the appearance of both conditions - with the degree of improvement depending heavily on the type, age, and location of the marks.

The two conditions are covered separately below because the mechanisms, evidence, and realistic expectations differ between them.

Stretch marks: what they are and why the type matters enormously

A stretch mark - technically called striae distensae - forms when the skin is stretched faster than the dermis can adapt. The collagen and elastin fibres in the deeper skin layer tear, and the marks that form are essentially a type of dermal scar. They are not a superficial skin problem. They sit in the dermis, not the epidermis, which is why no cream or moisturiser has ever significantly changed them - topical ingredients cannot reach the structural layer where the damage is.

The distinction between red/purple stretch marks and white/silver ones is not just cosmetic - it reflects completely different biology, and it determines how much any treatment, including red light therapy, can realistically do.

Striae rubra - newer marks Red, pink, or purple stretch marks

Active inflammation is still present. Blood vessels are visible through the skin. The remodelling process is ongoing, which means fibroblasts are still active and collagen production is still happening. This is the window where intervention has the most to work with.

PBM response: strong. The anti-inflammatory and collagen-stimulating effects align directly with what the tissue is already trying to do. Clinical studies show significant improvement in texture, colour, and elevation.
Striae alba - older marks White or silver stretch marks

The inflammatory phase has resolved. The marks have become hypopigmented, atrophic scars with minimal residual cellular activity. The structural damage is largely set. This does not mean treatment is futile, but the biology is more difficult and results are slower and more modest.

PBM response: moderate. Improvement in texture and modest changes in pigmentation are achievable with consistent long-term use. Combining PBM with microneedling produces better outcomes for alba than PBM alone.

A note on skin tone

The 2024 RCT comparing PBM to fractional CO2 for striae alba specifically recruited patients with Fitzpatrick phototypes III-IV - darker skin tones - and found PBM performed comparably with a better safety profile than ablative laser, which carries higher risk of post-inflammatory hyperpigmentation in darker skin. The 2024 JAAD paper on PBM and skin of colour notes that visible red light (630-660nm) can interact with melanin in Fitzpatrick types IV-VI, and recommends starting at lower parameters. If you have a darker skin tone, begin with shorter sessions and lower power settings and build up gradually. NIR wavelengths (810-850nm) carry lower risk in this regard as they do not target melanin as a primary chromophore.

What the clinical evidence shows

The most directly relevant clinical study is a 2023 prospective pilot study (PMID 37241073) evaluating a 675nm diode laser on 32 women with striae distensae across the abdomen, thighs, buttocks, and breasts. Three monthly sessions produced statistically significant improvement in Manchester Scar Scale scores - from a baseline of 14.16 to 10.06 at six-month follow-up (p less than 0.01). The 675nm wavelength is close to the 660nm red light in standard panels and mechanistically equivalent, though this was a clinical laser rather than a home LED device.

A 2024 RCT (PMC11189306) compared photobiomodulation directly against fractional CO2 laser for striae alba in patients with Fitzpatrick phototypes III-IV. At three months post-treatment, PBM patients showed 40-47.5% global improvement scores. The fractional CO2 performed better on most measures, but PBM had a significantly more favourable tolerability profile and no downtime - relevant for people who want improvement without the recovery period associated with ablative laser.

The 2023 systematic review by de Souza et al. in Lasers in Medical Science (38:170) reviewed the available literature on PBM for striae distensae and found consistent positive results across included studies, with improvements in texture, colour, and patient satisfaction. Wang et al. (J Cosmet Dermatol 2023;22(3):856-865) conducted a systematic review and meta-analysis of LLLT for striae and reached similar conclusions. An earlier pilot study by Kim et al. (Lasers Surg Med 2011;43(6):503-509) using 633nm and 830nm light found improvements in both rubra and alba marks, with rubra showing stronger responses.

29% reduction in Manchester Scar Scale score after three monthly 675nm laser sessions in 32 women with striae distensae (PMID 37241073, p less than 0.01)
80% of adults have stretch marks to some degree - they are one of the most common dermatological concerns with very few effective at-home treatment options
6M follow-up period in the 2023 pilot study showing maintained improvement - suggesting collagen remodelling effects are durable rather than temporary

Setting realistic expectations

Red light therapy can improve the appearance of stretch marks - texture, colour, and surface quality. It cannot remove them. The structural changes in the dermis are permanent; what changes is how the tissue looks and feels as collagen remodelling improves the density and organisation of the surrounding skin. Newer red or pink marks respond noticeably. Older white or silver marks improve more slowly and to a lesser degree. For alba specifically, combining PBM with microneedling - which creates controlled micro-injury to reactivate fibroblast activity - produces better results than either approach alone.

Cellulite: a structural problem that runs deeper than the skin surface

Cellulite is not simply a fat problem, which is why it appears in slim people and why weight loss does not reliably eliminate it. The characteristic dimpled appearance comes from the way fat lobules in the hypodermis push upward through vertical fibrous septae into the dermis - when those septae are taut and the fat lobules beneath are enlarged, the skin surface buckles. Underneath that, poor lymphatic and blood vessel circulation creates a hypoxic environment that drives further fat cell enlargement and connective tissue fibrosis. It is a structural and microvascular condition, not just an aesthetic one.

Photobiomodulation addresses this from multiple angles. The primary mechanism for cellulite is different from stretch marks - rather than collagen remodelling in the dermis, the relevant effects are lipolysis in the adipocyte layer, improved lymphatic and circulatory function, and reduction of the local inflammation that perpetuates the fibrotic changes in the connective tissue.

How PBM addresses cellulite - three distinct pathways

Pathway 1

Lipolysis

PBM activates cytochrome c oxidase and upregulates cAMP, which stimulates cytoplasmic lipase and converts triglycerides into fatty acids. This promotes fat cell reduction in the hypodermis - the layer where cellulite originates.

Pathway 2

Circulation and lymphatics

Nitric oxide production from PBM improves local blood flow. Enhanced circulation and lymphatic drainage reduce the fluid retention and tissue oedema that contribute to the visible surface irregularity of cellulite.

Pathway 3

Connective tissue remodelling

The fibrous septae that cause the dimpled appearance become thickened and fibrotic over time. PBM's anti-inflammatory effects and collagen remodelling mechanisms support more organised connective tissue structure and reduce the progressive fibrosis that worsens cellulite with age.

The clinical evidence for PBM in cellulite is real but more mixed in quality than for stretch marks. A 2025 study published in the Journal of Cosmetic Dermatology (Nishioka et al., DOI 10.1111/jocd.16675) examined LED PBM protocols specifically for abdominal adipose tissue reduction and found measurable reductions in fat layer thickness with consistent treatment. Savoia et al. (Dermatol Ther 2013;3:41-52) combined LLLT with vibration therapy for localised adiposity and fibrous cellulite, finding significant improvements in clinical grading and patient-reported outcomes. Multiple studies report positive results, but methodological inconsistency across trials makes drawing firm conclusions difficult - which is an honest limitation to acknowledge.

The honest summary: PBM for cellulite has a plausible and well-characterised mechanism, positive results in multiple studies, and a growing evidence base - but the quality of that evidence is variable and the effect size is moderate. It works best as part of a broader approach that includes exercise and hydration rather than as a standalone fix. The dimpled appearance of established cellulite reflects structural anatomy as much as it does tissue quality, and light therapy alone cannot change the underlying anatomy.

What cellulite treatment can and cannot achieve

PBM can reduce the severity of cellulite appearance by improving local circulation, reducing adipose tissue volume, and improving connective tissue quality. It cannot permanently eliminate cellulite, change the underlying anatomy of the fibrous septae, or produce the kind of results associated with clinical treatments like subcision or acoustic wave therapy. What it offers is a consistent, non-invasive way to maintain and gradually improve skin quality in affected areas - which, for most people, is a reasonable and achievable goal.

80% of adults have cellulite to some degree - it is a structural condition, not a weight problem, which is why it appears in slim people and why weight loss alone does not reliably eliminate it
3 distinct pathways through which PBM addresses cellulite: lipolysis via cAMP activation, circulation via nitric oxide, and connective tissue remodelling via anti-inflammatory effects
2025 Journal of Cosmetic Dermatology study confirmed measurable reductions in abdominal fat layer thickness with consistent LED PBM protocols (Nishioka et al., DOI 10.1111/jocd.16675)

How to use a panel for both conditions

The protocols for stretch marks and cellulite differ slightly because the target tissue and depth of action differ. Both benefit from regular consistent use over weeks - neither responds to occasional sessions.

For stretch marks 660nm red, 3-5x weekly, 8-16 weeks minimum

660nm red light targets the dermis where stretch marks live. Adding 850nm NIR reaches deeper for systemic collagen support. Apply 10-20 J/cm2 per session, 3-5 times per week. For rubra marks, 8-12 weeks of consistent use typically shows visible improvement. For alba, 16+ weeks with consistent use is more realistic. Hold the panel 10-15cm from the skin surface. Do not use over broken or irritated skin.

For cellulite 850nm NIR priority, 4-5x weekly, longer sessions

NIR at 810-850nm penetrates deeper into the hypodermis where fat cells and lymphatic tissue sit. Red at 660nm addresses the dermal connective tissue layer simultaneously. Longer sessions of 15-20 minutes directly over affected areas (abdomen, thighs, buttocks) 4-5 times per week. Combine with exercise on the same day where possible - the increased circulation from exercise amplifies lymphatic clearance of the fatty acids mobilised by lipolysis.

Timing Earlier is always better for stretch marks

For stretch marks specifically, the single most important variable is when you start. Red/pink rubra marks have active cellular processes that PBM can work with directly. Starting treatment during or shortly after the event causing the marks - pregnancy, rapid growth phase, weight change - gives the best possible window. Once marks turn white or silver, the biology is harder and the results are more modest.

Combination approaches What works alongside PBM

For stretch marks: microneedling between PBM sessions reactivates fibroblasts in older alba marks and creates synergistic collagen stimulation. For cellulite: exercise, hydration, and dry body brushing all support lymphatic function and amplify PBM's circulatory effects. Neither condition is well served by PBM alone without addressing the broader lifestyle factors that influence skin quality and adipose tissue health.

Key takeaways

  • Stretch marks are dermal scars sitting in the deep skin layer - no topical treatment reaches them. PBM works at the right depth to stimulate fibroblasts and collagen remodelling where the damage actually is.
  • Striae rubra (red/pink) respond significantly better than striae alba (white/silver). A 2023 clinical study found a 29% improvement in scar scores after three monthly sessions; a 2024 RCT found 40-47% global improvement scores with PBM for alba marks.
  • For cellulite, PBM targets three pathways: lipolysis in the fat layer (via cAMP and lipase activation), improved lymphatic circulation (via nitric oxide), and connective tissue remodelling. Effect is moderate and works best alongside exercise.
  • Neither condition is cured by red light therapy. What changes is tissue quality, colour, texture, and the severity of appearance - all of which are meaningful improvements for the people who care about them.
  • Consistency is everything. 3-5 sessions per week over 8-16 weeks is the minimum to see meaningful change. Occasional use produces little. The effects accumulate over time rather than appearing after a single session.

The honest bottom line

Stretch marks and cellulite are two of the most marketed-to conditions in the beauty industry, which means there is an enormous amount of overclaiming in this space. Creams that claim to remove stretch marks, treatments that promise to eliminate cellulite permanently, devices that claim dramatic results from a few sessions. None of that holds up to scrutiny.

What red light therapy offers is more modest and, in some ways, more useful: a consistent, non-invasive way to work with the skin's own repair processes to gradually improve tissue quality in affected areas. The clinical evidence for stretch marks is solid enough to recommend it with confidence, particularly for rubra marks where the timing is right. The evidence for cellulite is real but more variable, and works best as part of a broader approach rather than a standalone solution.

For conditions that affect the majority of adults and have historically been served poorly by available treatments, that is a more credible offer than most products in this space make.

Sources

Prospective pilot study. 32 women with striae distensae on abdomen, thighs, buttocks, and breasts. Three sessions of 675nm RedTouch diode laser (DEKA M.E.L.A.) with one-month intervals. Manchester Scar Scale used to assess changes. Mean scores: baseline 14.16 (±1.30), 6-month follow-up 10.06 (±1.32). Statistically significant improvement (p less than 0.01). Dermatol Ther (Heidelb) 2023;13(6):1323-1333. PMID: 37241073. DOI: 10.1007/s13555-023-00934-2.
Randomised controlled trial comparing PBM versus fractional carbon dioxide laser for striae alba in patients with Fitzpatrick phototypes III-IV. At 3 months post-treatment, PBM group: patient global assessment of improvement 40%, physician global assessment 47.5%, patient satisfaction 50%. Fractional CO2 produced superior outcomes on most measures but PBM had significantly better tolerability and no downtime. Lasers Med Sci 2024. PMC: 11189306.
Systematic review of PBM for striae distensae treatment. Reviewed available clinical literature for evidence of efficacy across different PBM protocols, wavelengths, and striae types. Found consistent positive results across included studies for texture, colour, and patient satisfaction outcomes. Lasers Med Sci 2023;38(1):170. DOI: 10.1007/s10103-022-03694-z.
Systematic review and meta-analysis of low-level laser therapy for the treatment of striae distensae. Searched multiple databases for RCTs and clinical studies. Found statistically significant improvement in stretch mark appearance across pooled data. J Cosmet Dermatol 2023;22(3):856-865. DOI: 10.1111/jocd.15559.
Pilot study using 633nm red light and 830nm near-infrared light for patients with striae distensae. Found improvements in both rubra and alba mark types, with rubra showing stronger and faster responses. Established the foundational clinical evidence for dual-wavelength PBM in stretch mark treatment. Lasers Surg Med 2011;43(6):503-509. PMID: 21674554. DOI: 10.1002/lsm.21076.
Clinical protocol study examining effects of LED photobiomodulation therapy for reducing adipose tissue in the abdominal region. Physiological mechanism described: PBM activates cytochrome c oxidase, upregulates cAMP, stimulates cytoplasmic lipase and converts triglycerides into fatty acids available for metabolism. Measurable reductions in fat layer thickness found with consistent treatment protocol. J Cosmet Dermatol 2025. DOI: 10.1111/jocd.16675.
Clinical study combining low-level laser therapy with vibration therapy for the treatment of localised adiposity and fibrous cellulite. Found significant improvements in clinical cellulite grading and patient-reported outcomes. Established the anti-cellulite mechanism of LLLT via lymphatic drainage, fat cell reduction, and connective tissue effects. Dermatol Ther (Heidelb) 2013;3(1):41-52. DOI: 10.1007/s13555-013-0026-x.
Share

NovaThera

Built on verified science.

660nm red and 850nm NIR - the wavelength combination used across the stretch mark and skin remodelling research. Published irradiance data, no overclaiming.

660 nm red
850 nm NIR
Published irradiance data
UK owned and supported
Explore NovaThera panels
Back to blog

Leave a comment